Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health - Institut Pierre Louis d'Epidémiologie et de Santé Publique Access content directly
Journal Articles BMJ Evidence-Based Medicine Year : 2023

Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health

Abstract

No abstract available
Fichier principal
Vignette du fichier
bmjebm-2022-112091.full.pdf (257.38 Ko) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-04056273 , version 1 (30-05-2023)

Licence

Attribution - NonCommercial

Identifiers

Cite

Antoine Vanier, Judith Fernandez, Sophie Kelley, Lise Alter, Patrick Semenzato, et al.. Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health. BMJ Evidence-Based Medicine, 2023, pp.bmjebm-2022-112091. ⟨10.1136/bmjebm-2022-112091⟩. ⟨hal-04056273⟩
71 View
13 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More